What are the guidelines for managing cluster headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Cluster Headache

Acute Treatment

For acute cluster headache attacks, use subcutaneous sumatriptan 6 mg or high-flow oxygen (100% at 12 L/min) as first-line therapy, both achieving relief in approximately 70% of patients within 10-15 minutes. 1, 2

First-Line Acute Therapies

  • Subcutaneous sumatriptan 6 mg is the most effective acute treatment, with 70% of patients achieving relief within 10 minutes and 74% within 15 minutes 1, 2, 3

    • Pain freedom occurs in 48-49% of patients at 1 hour 3
    • The 12 mg dose offers no additional benefit over 6 mg but increases adverse events 4
    • Screen for cardiovascular risk factors (hypertension, hypercholesterolemia, smoking, obesity, diabetes, family history of CAD) before prescribing, as triptans cause vasoconstriction 2
  • 100% oxygen inhalation at 12 L/min provides equal efficacy to sumatriptan, with 70% of patients achieving relief within 10 minutes 2

    • This is the preferred option for patients with cardiovascular contraindications to triptans 1

Alternative Acute Therapy

  • Intranasal zolmitriptan 10 mg is an effective alternative when subcutaneous administration is not feasible 1, 5

Non-Invasive Neuromodulation

  • Non-invasive vagus nerve stimulation is recommended specifically for episodic cluster headache when medications are contraindicated or poorly tolerated 1, 6

Preventive Treatment

Verapamil is the prophylactic drug of choice, starting at 360 mg/day, with ECG monitoring for PR interval prolongation at higher doses. 2

First-Line Preventive Therapy

  • Verapamil 360 mg/day is the most established preventive treatment 2, 5
    • Monitor ECG for PR interval prolongation, especially at higher doses 2
    • Titrate slowly to effective dose while monitoring for adverse effects 5

Newer Preventive Options

  • Galcanezumab (CGRP monoclonal antibody) is effective for episodic cluster headache only, not for chronic cluster headache 2
    • This represents a significant advancement for patients with episodic patterns 6

Additional Preventive Agents

  • Lithium is particularly useful for chronic cluster headache and can be added to verapamil for refractory cases 2, 5
  • Topiramate and divalproex sodium may be considered as add-on therapy for chronic cluster headache 2, 5

Bridging Therapy

Use oral corticosteroids or greater occipital nerve blockade as bridging therapy while waiting for verapamil to take effect, as preventive medications require 2-3 weeks to become effective. 2, 5

Bridging Options

  • Oral prednisolone provides rapid temporary relief during the initiation of preventive therapy 5
  • Greater occipital nerve blockade offers an alternative bridging approach, particularly for patients who cannot tolerate corticosteroids 2, 5

Treatment Algorithm by Cluster Headache Type

Episodic Cluster Headache

  1. Acute attacks: Subcutaneous sumatriptan 6 mg OR 100% oxygen at 12 L/min 1, 2
  2. Bridging: Oral corticosteroids or occipital nerve block 2, 5
  3. Prevention: Verapamil 360 mg/day OR galcanezumab 2
  4. Alternative prevention: Lithium, topiramate, or divalproex sodium 2, 5

Chronic Cluster Headache

  1. Acute attacks: Same as episodic (sumatriptan or oxygen) 1, 2
  2. Prevention: Verapamil as first-line 2, 5
  3. Refractory cases: Add lithium, topiramate, or divalproex sodium 2
  4. Note: Galcanezumab is NOT effective for chronic cluster headache 2

Invasive Interventions for Refractory Cases

  • Implantable sphenopalatine ganglion stimulator is recommended against for cluster headache treatment 1
  • Occipital nerve stimulation may be considered for drug-refractory chronic cluster headache when all medical treatments have failed 6, 7

Critical Diagnostic Considerations

Distinguish cluster headache from migraine by the shorter attack duration (15-180 minutes vs 4-72 hours), presence of ipsilateral autonomic symptoms (lacrimation, rhinorrhea, conjunctival injection), and restless behavior during attacks (pacing) rather than lying still. 2

Red Flags Requiring Neuroimaging

  • Focal neurological deficits 2
  • Atypical headache pattern 2
  • Progressive worsening 2
  • New neurological symptoms or abnormal examination 2
  • MRI brain is the preferred imaging modality 2

Comparative Effectiveness

  • There is insufficient evidence to recommend one specific medication over another for cluster headache prevention 1
  • There is insufficient evidence to recommend specific combination therapies 1
  • However, clinical practice strongly favors verapamil as first-line based on the most robust evidence base 2, 5

Common Pitfalls to Avoid

  • Do not use oral triptans for cluster headache—the rapid onset requires subcutaneous or intranasal routes 6, 5
  • Do not prescribe sumatriptan without cardiovascular screening, as the severe pain may mask cardiac symptoms 2
  • Do not expect immediate effect from verapamil—bridging therapy is essential during the 2-3 week onset period 2
  • Do not use galcanezumab for chronic cluster headache—it is only effective for episodic patterns 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cluster Headache Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of cluster headache: clinical trials, design and results.

Cephalalgia : an international journal of headache, 1995

Research

Management of cluster headache: Treatments and their mechanisms.

Cephalalgia : an international journal of headache, 2023

Research

Cluster headache: pharmacological treatment and neurostimulation.

Nature clinical practice. Neurology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.